Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Hepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001712
What this trial is testing

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

Who this might be right for
Hepatitis BHepatitis CHIV Infection
National Institutes of Health Clinical Center (CC) 3,400
Not applicableStudy completedNCT00001119
What this trial is testing

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 288
Not applicableStudy completedNCT01924455
What this trial is testing

HBV-HIV Coinfection Research Network

Who this might be right for
Hepatitis BHuman Immunodeficiency Virus
Virginia Commonwealth University 139
Large-scale testing (Phase 3)Study completedNCT02639338
What this trial is testing

Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 220
Testing effectiveness (Phase 2)Study completedNCT01777295
What this trial is testing

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Who this might be right for
Hepatitis B
GlaxoSmithKline 81
Post-approval studies (Phase 4)Study completedNCT02463331
What this trial is testing

Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial

Who this might be right for
Autoimmune Hepatitis
University of Sao Paulo General Hospital 57
Large-scale testing (Phase 3)Ended earlyNCT01694264
What this trial is testing

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Who this might be right for
Chronic Hepatitis BRheumatoid ArthritisAnkylosing Spondylitis+2 more
Seoul National University Hospital 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06993480
What this trial is testing

Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01548690
What this trial is testing

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

Who this might be right for
Acute Liver FailureAcute Liver Injury
William Lee 47
Not applicableStudy completedNCT02116179
What this trial is testing

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHepatitis C
University of Delaware 201
Testing effectiveness (Phase 2)Looking for participantsNCT07378761
What this trial is testing

Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis

Who this might be right for
Immune-Mediated Cholestasis
University Hospital, Montpellier 94
Not applicableStudy completedNCT03155984
What this trial is testing

Optimizing HBV Management During Anti-CD20 Antibodies

Who this might be right for
Liver DysfunctionImmune SuppressionHepatitis B
The University of Hong Kong 83
Post-approval studies (Phase 4)Study completedNCT00684671
What this trial is testing

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 506
Testing effectiveness (Phase 2)Study completedNCT00959699
What this trial is testing

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Who this might be right for
HIV InfectionsHepatitis CHCV Infection
Merck Sharp & Dohme LLC 99
Not applicableWithdrawnNCT00165919
What this trial is testing

Immune Response to Hepatitis C Virus

Who this might be right for
Hepatitis CHIV Infections
Emory University
Large-scale testing (Phase 3)Study completedNCT00480792
What this trial is testing

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 437
Large-scale testing (Phase 3)UnknownNCT00451984
What this trial is testing

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

Who this might be right for
HIV InfectionsHepatitis AHepatitis B
Aalborg University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00033163
What this trial is testing

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Early research (Phase 1)Study completedNCT05561673
What this trial is testing

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Who this might be right for
Hepatitis B
GlaxoSmithKline 122
Next Page